Patients with type 2 diabetes treated with insulin could be exposed to a greater risk of health complications including heart attack, stroke, cancer and eye complications a new study has found. Examining the UK Clinical Practice Research Datalink (CPRD) – data that characterizes about 10 percent of the UK population – a team of researchers…
TEAM FENFURO particpated in 32nd Edition of India International Trade Fair (IITF) held at Pragati Maidan from November 14th to 27th, 2012. IITF is the largest trade fair in this part of the world. This year the theme was “Skilling India”
We are glad to inform that our Company has been awarded OUTSTANDING CONTRIBUTION TO NATIONAL DEVELOPMENT
Our company has been declared a WINNER in overall evaluation for INDIA SME TOP 100 AWARDS amongst 49023 nominations.
Poster Presentation on “CLINICAL EVALUATION OF FENFURO (FUROSTANOLIC SAPONINS) IN PATIENTS WITH TYPE-2 DIABETES
Poster Presentation on “CLINICAL EVALUATION OF FENFURO (FUROSTANOLIC SAPONINS) IN PATIENTS WITH TYPE-2 DIABETES” at 6th World Congress of Diabetes India held on 9thto 12thApril at Hotel ITC Grand Chola Convention Centre Chennai.
Poster Presented on “A Muti-centric placebo-controlled double-blind clinical study to determine the efficacy of a novel fenugreek seed (Trigonella foenum-graecum, FENFUROTM) extract in patients with Type-2 diabtes: an add-on study at Diabetes UK Professional Conference, Glasgow, UK on 2-4 March 2016.
Washington, Jan 10 : Middle-aged adults who are recently diagnosed with diabetes and hypertension have at least one year time to try to learn how to control their high blood pressure without medications, but further delay can increase damage, a new study has suggested. The consequences of delaying effective hypertension treatment for up to a…
Team Furocyst had conducted the CME conference of Obs./Gyn. doctors- Mohali Chapter on 6th January, 2016 at Hotel Cama, Mohali.
Speaker Dr Vinnet Nagpal, Sr consultant at Civil Hospital, mohali made emphatic remarks on study results of Furocyst & suggested to
prescibed as alternate nutritional/dietary supplement option to pcos patients.
Hon’able Sh.Nitin Gadkari, Union Transport and Highways Minister visited our stall at R&D Sumit, Vigyan Bhawan, New Delhi on dated 07-08 December, 2015
Abstract accepted as a poster presentation at the 43rd annual conference of Research Society for the Study of Diabetes in India – RSSDI 2015 at Lucknow, UP
Abstract has been accepted as a poster presentation- ‘Clinical evaluation of fenugreek seed extract (Fenfuro) in patients with type-2 diabetes: an add-on study in 154 patients’ at the 43rd annual conference of Research Society for the Study of Diabetes in India – RSSDI 2015 at Lucknow, UP (30th, 31st October & 1st November 2015).